Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
1 Year Est. Return
+47.06%
AUM
$24.6B
AUM Growth
-$4.32B
(-15%)
Holding
1,158
Top Buys
| 1 | +$417M | |
| 2 | +$152M | |
| 3 | +$74.2M | |
| 4 |
Qualcomm
QCOM
|
+$39.4M |
| 5 |
Marvell Technology
MRVL
|
+$24.7M |
Top Sells
| 1 | +$647M | |
| 2 | +$341M | |
| 3 | +$243M | |
| 4 |
Lam Research
LRCX
|
+$194M |
| 5 |
NVIDIA
NVDA
|
+$191M |
Sector Composition
| 1 | Technology | 48.84% |
| 2 | Financials | 8.23% |
| 3 | Consumer Discretionary | 5.72% |
| 4 | Healthcare | 3.78% |
| 5 | Industrials | 3.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Green Plains
GPRE
$1.05B
| $2.07M | 0.01% |
125,652
+9,807
|
|
||
602
Celldex Therapeutics
CLDX
$2.25B
| $2.06M | 0.01% |
65,050
-49,180
|
|
||
603
Century Communities
CCS
$1.6B
| $2.06M | 0.01% |
35,937
-5,901
|
|
||
604
Tapestry
TPR
$28.3B
| $2.05M | 0.01% |
14,540
-6,700
|
|
||
605
Sysco
SYY
$36.5B
| $2.04M | 0.01% |
28,667
-11,437
|
|
||
606
Nicolet Bankshares
NIC
$2.92B
| $2.03M | 0.01% |
13,653
-522
|
|
||
607
Novavax
NVAX
$1.56B
| $2.02M | 0.01% |
248,413
-81,073
|
|
||
|
BKV
608
BKV Corp
BKV
$2.84B
| $2.02M | 0.01% |
70,822
+35,042
|
|
||
609
Expedia Group
EXPE
$27.5B
| $2.01M | 0.01% |
8,702
-2,949
|
|
||
610
Equity Residential
EQR
$25.6B
| $2M | 0.01% |
33,826
-10,941
|
|
||
611
Snowflake
SNOW
$82.6B
| $1.99M | 0.01% |
13,213
-3,275
|
|
||
|
ORKA
612
Oruka Therapeutics
ORKA
$3.63B
| $1.99M | 0.01% |
40,487
+2,002
|
|
||
613
Mettler-Toledo International
MTD
$23.3B
| $1.98M | 0.01% |
1,570
-628
|
|
||
614
Kenvue
KVUE
$34B
| $1.98M | 0.01% |
114,680
-45,766
|
|
||
615
EPAM Systems
EPAM
$5.12B
| $1.97M | 0.01% |
14,519
-4,810
|
|
||
616
Olema Pharmaceuticals
OLMA
$901M
| $1.96M | 0.01% |
131,520
+86,515
|
|
||
617
Factset
FDS
$9.31B
| $1.96M | 0.01% |
9,018
-2,410
|
|
||
618
Otis Worldwide
OTIS
$27B
| $1.95M | 0.01% |
25,311
-9,405
|
|
||
619
Stoke Therapeutics
STOK
$1.87B
| $1.95M | 0.01% |
59,898
-30,295
|
|
||
620
CMS Energy
CMS
$22.3B
| $1.92M | 0.01% |
24,796
-8,717
|
|
||
621
Kimberly-Clark
KMB
$32.9B
| $1.92M | 0.01% |
19,864
-7,928
|
|
||
622
Vericel Corp
VCEL
$1.85B
| $1.91M | 0.01% |
59,395
-16,202
|
|
||
623
Capricor Therapeutics
CAPR
$1.55B
| $1.9M | 0.01% |
+62,353
|
|
||
624
Xylem
XYL
$26.1B
| $1.9M | 0.01% |
15,859
-5,830
|
|
||
625
Ingersoll Rand
IR
$28.3B
| $1.86M | 0.01% |
23,175
-8,855
|
|